This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares. In the severe acute respiratory syndrome coronavirus 2 pandemic era, inflammatory bowel disease course is not influenced by infection, while therapy discontinuation is a risk factor for disease flare.
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame
Balestrieri, Paola;
2023-01-01
Abstract
This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares. In the severe acute respiratory syndrome coronavirus 2 pandemic era, inflammatory bowel disease course is not influenced by infection, while therapy discontinuation is a risk factor for disease flare.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
izac173.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
135.92 kB
Formato
Adobe PDF
|
135.92 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
